Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
15,168,828
-
Shares change
-
-5,023,508
-
Total reported value, excl. options
-
$25,334,849
-
Value change
-
-$9,375,811
-
Put/Call ratio
-
63%
-
Number of buys
-
33
-
Number of sells
-
-41
-
Price
-
$1.67
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2022
92 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q2 2022.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,168,828 shares
of 79,794,643 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include Yong Rong (HK) Asset Management Ltd (2,709,036 shares), Tieton Capital Management, LLC (2,285,015 shares), VANGUARD GROUP INC (2,182,444 shares), ICONIQ Capital, LLC (1,296,354 shares), BlackRock Inc. (988,876 shares), MILLENNIUM MANAGEMENT LLC (763,593 shares), RENAISSANCE TECHNOLOGIES LLC (739,900 shares), GEODE CAPITAL MANAGEMENT, LLC (548,737 shares), CITADEL ADVISORS LLC (373,557 shares), and GOLDMAN SACHS GROUP INC (323,078 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.